ArticleOral diseases2026

CD4+ T Cells Predict Relapse in Pemphigus Vulgaris Treated With Rituximab: A Retrospective Study.

Simone Liguori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.